clinical trials
From Lab to Lifeline: Anthony Atala’s Vision for Bioprinting at WFIRM
Anthony Atala is transforming the future of medicine—not just with a scalpel, but with a bioprinter. As the director of the Wake Forest Institute for Regenerative Medicine (WFIRM), he’s pushing…
BellaSeno’s Clinical Trial on 3D-Printed Breast Implants Shows Promising Early Results
Bioprinting firm BellaSeno has provided a public update on its ongoing clinical trial for resorbable breast scaffolding. The trial uses patients’ own fat with a 3D-printed scaffold, which gradually reabsorbs…
BellaSeno’s Pioneering 3D Printing Facility for Medical Implants to Open in 2025
German 3D printing medical implant pioneer BellaSeno plans to launch a fully automated production facility in Australia by mid-2025 to make its resorbable soft tissue and bone reconstruction implants. By…
FDA Greenlights RevBio’s Innovative Bone Glue Trial for Cranial Surgery
The U.S. Food and Drug Administration (FDA) has given the green light for a new clinical trial to test a novel bone adhesive, a material designed to bond bones together…
Triastek Discusses Three 3D Printed Medications Now Being Studied
Progress in additive manufacturing (AM) for medication is much farther along than might be suggested by the relative scarcity of coverage on the subject in trade publications. One reason for…
3D Printed Breast & Chest Implants Enter Clinical Trials
Medtech company BellaSeno GmbH, headquartered in Leipzig, Germany, with its BellaSeno Pty subsidiary in Brisbane, Australia, specializes in the development of resorbable soft tissue and bone reconstruction implants, made with…
Eli Lilly to Explore New 3D Printed Pharmaceuticals with Triastek
Triastek and Eli Lilly have announced that the two companies will collaborate on the research of new applications for 3D printed pharmaceuticals. Specifically, the research will focus on utilizing Triastek’s…
